Bibhitaki
CombretaceaeTerminalia bellirica
Also known as: Baheda, Bahera, Bastard Myrobalan
clinical_notes Clinical Summary
Bibhitaki (Terminalia bellirica) is the middle fruit of the Ayurvedic Triphala formula alongside Amalaki and Haritaki.
Rich in gallotannins and chebulagic acid, it provides gentle laxative, astringent, and rejuvenative (rasayana) actions.
A randomized clinical pilot showed 500 mg significantly reduced serum uric acid in hyperuricemia, and triphala-level research supports its roles in dyslipidemia, dental health, and antioxidant support.
Traditionally avoided in pregnancy and lactation.
Pregnancy Safety
Traditional Ayurvedic contraindication; safety not established. Avoid therapeutic doses in pregnancy.
Lactation Safety
Reported to decrease breast milk supply in Ayurvedic literature; avoid during lactation.
warning Contraindications
- Pregnancy (avoid)Theoretical
- Lactation (avoid)Theoretical
- Concurrent anticoagulant therapy (caution)Theoretical
- Concurrent oral medications (caution)Theoretical
- Dehydration or debility (caution)Theoretical
vital_signs Clinical Profile
Primary Indications
- check_circle chronic constipation (component of Triphala)
- check_circle hyperuricemia
- check_circle cough with excess mucus
- check_circle bronchitis
- check_circle dyslipidemia
- check_circle metabolic syndrome
- check_circle fatty liver
- check_circle hair loss
- check_circle dental and gum issues
Therapeutic Actions
System Affinities
- check_circle respiratory system
- check_circle digestive system
- check_circle hepatic
- check_circle hair/eyes
- check_circle urinary system
labs Active Constituents
chebulagic acid
chebulinic acid
gallotannins
ellagic acid
gallic acid
beta-sitosterol
bellericoside
bellericanin
termilignan
thannilignan
anthraquinone glycosides
mannitol
phyllemblin
history_edu Traditional Use
No TCM data available for this herb yet.
Traditional Uses Across Healing Systems
While many herbs lack controlled clinical trials, centuries of traditional practice across cultures provide valuable insight into their therapeutic applications.
One of three fruits in Triphala - the classic tridoshic rasayana formula for digestion, elimination, and rejuvenation. Also used singly for cough, hair, eye health, and hoarseness.
Kapha-Pitta balancing; classified as bhedanam (laxative), netra hitam (good for eyes), keshya (good for hair).
Known as Balela; used for digestive complaints, cough, and as an astringent.
Introduced through trade with India.
Sanguo Fang (Triphala) introduced to China via Buddhist monks during the Tang Dynasty (618-907 CE). Terminalia bellirica and T. chebula both used in Tibetan medicine.
Listed in Tang Guo Shi Bu and Qian Jin Yao Fang.
Used by various South Asian tribes for traditional woundcare, dental health, and digestion.
spa Parts Used
fruit
- constipation
- hyperuricemia
- dyslipidemia
- cough
Dried ripe fruit without seed; ground to powder (churna) or combined with other myrobalans as Triphala.
seed
- hair care
- nasya (nasal oil)
Seed kernels pressed to make Aksha Taila (Baheda oil) used for hair growth and nasal application.
shield Safety
Contraindications — Evidence Basis
Pregnancy
Traditional texts advise avoidance in pregnancy; may reduce breast milk production.
Lactation
Bibhitaki is reported to decrease breast milk; avoid during lactation per traditional Ayurvedic teaching.
Concurrent anticoagulant therapy
Tannins and antioxidants may theoretically affect bleeding; Triphala has been shown to interact with warfarin.
Concurrent oral medications
High tannin content may reduce absorption of alkaloid-based drugs and iron; separate by 2 hours.
Dehydration or debility
Mild laxative effect and dry quality; not recommended in patients with severe dehydration or emaciation per Ayurvedic practice.
Monitoring Parameters
Monitor during use, especially with prolonged or high-dose therapy.
Serum uric acid
Baseline and at 4-8 weeks (hyperuricemia patients)RCT shows T. bellirica reduces uric acid via xanthine oxidase inhibition.
flagThreshold: Target <6 mg/dL for gout management.
Lipid profile
Baseline and at 3 monthsHypolipidemic effect documented in animal and human studies.
flagThreshold: Monitor for therapeutic response.
Toxicity
Well tolerated up to 3 g/day in studies. Excessive doses may cause dry skin and constipation (paradoxical).
Constipation, dry skin, reduced androgens/sperm motility with chronic oral dosing.
Reduce dose or discontinue; hydration.
Adverse Effects
CYP Metabolism
Triphala (containing bibhitaki) shown to modulate CYP3A4 in vitro; clinical significance not well established.
swap_horiz Interactions
Warfarin
Class: Anticoagulant
Terminalia bellirica and its combination Triphala show antiplatelet and mild fibrinolytic activity; hydrolyzable tannins and gallic acid inhibit platelet aggregation. A clinical case of INR rise with Triphala co-administration has been reported.
Monitor INR weekly for 2-4 weeks when starting or stopping bibhitaki or Triphala. Avoid around surgery.
Losartan
Class: Angiotensin receptor blocker (ARB)
Bibhitaki inhibits CYP3A4 and partially CYP2C9 in vitro, enzymes that convert losartan to its active metabolite EXP3174 (opposite effect possible) and metabolize losartan itself; interaction is complex but clinically relevant PK changes are plausible.
Monitor blood pressure response when initiating bibhitaki or Triphala. Consider alternative ARB in patients with difficult-to-control hypertension.
Metformin
Class: Biguanide antidiabetic
Bibhitaki (and Triphala) reduce fasting blood glucose and HbA1c in clinical trials through alpha-glucosidase and alpha-amylase inhibition and enhanced insulin sensitivity, additive to metformin.
Monitor glucose at initiation. Reduce antidiabetic dose if symptomatic hypoglycemia occurs.
Atorvastatin
Class: HMG-CoA reductase inhibitor (statin)
Atorvastatin is a CYP3A4 substrate; bibhitaki's CYP3A4 inhibition may modestly raise statin AUC and risk of myopathy or hepatic toxicity.
Consider rosuvastatin (not CYP3A4 metabolized) in patients on high-dose bibhitaki. Monitor CK if muscle symptoms develop.
Levothyroxine
Class: Thyroid hormone
Tannins and the mild laxative effect of bibhitaki may reduce intestinal absorption of levothyroxine when taken concurrently.
Separate doses by at least 4 hours. Recheck TSH 6-8 weeks after starting daily Triphala/bibhitaki.
Cyclosporine
Class: Immunosuppressant
Bibhitaki inhibits intestinal CYP3A4 and P-glycoprotein, the major determinants of cyclosporine bioavailability; concurrent use can raise cyclosporine trough levels and nephrotoxicity risk.
Avoid bibhitaki/Triphala in transplant patients. If unavoidable, monitor trough C0 weekly and adjust cyclosporine dose.
hub Combinations
Synergistic pairings can enhance therapeutic outcomes, while knowing suitable substitutes helps when specific herbs are unavailable or contraindicated.
Classical Formulas
2Amla
Strong EvidenceTriphala component; complementary actions - Amla pitta-cooling, Bibhitaki kapha-reducing, Haritaki vata-regulating.
Classic tridoshic formulation mentioned in Charaka Samhita.
Haritaki
Strong EvidenceAlong with Amla, forms Triphala - the foundational Ayurvedic tridoshic rejuvenative and gentle laxative formula.
Triphala extensively researched for GI health, oral health, hypolipidemic, and antioxidant effects.
Synergistic Combinations
2Black Pepper
Traditional UseBibhitaki with pippali (long pepper) and black pepper makes Trikatu-enhanced expectorant formula for lung congestion.
Traditional Ayurvedic formulation for kapha-type cough.
Ginger
Traditional UseGinger enhances digestive fire and respiratory action, complementing Bibhitaki's expectorant and mild laxative action for mucus-heavy cough.
Traditional Ayurvedic combination for kapha-type respiratory conditions.
science Studies
Anti Bacterial Efficacy of Terminalia Chebula, Terminalia Bellirica, Embilica Officinalis and Triphala on Salivary Streptococcus Mutans Count - A Linear Randomized Cross Over Trial
RCTThis double-blind, linear crossover randomized trial assessed the antibacterial efficacy of Terminalia bellirica aqueous extract rinse (along with T. chebula, Emblica officinalis, and combined Triphala) against salivary Streptococcus mutans counts at multiple time intervals. Participants rinsed with each preparation in a crossover design with washout periods. T. bellirica extract demonstrated significant reductions in S. mutans colony counts compared to baseline, supporting the traditional Ayurvedic use of Bibhitaki in oral hygiene. The study also documented the comparative efficacy of the individual plant extracts versus their combined Triphala formulation, providing evidence for the antimicrobial activity of T. bellirica against a key cariogenic bacterium.
In vitro antioxidant and inhibitory potential of Terminalia bellerica and Emblica officinalis fruits against LDL oxidation and key enzymes linked to type 2 diabetes
In VitroThis comparative in vitro study evaluated antioxidant and antidiabetic properties of various solvent extracts of Terminalia bellerica and Emblica officinalis fruit. Methanol extracts of T. bellerica showed the highest free radical scavenging activity against DPPH, superoxide, hydroxyl, and nitric oxide radicals. Both plants demonstrated potent inhibition of alpha-amylase and alpha-glucosidase enzymes relevant to postprandial glucose control, with T. bellerica methanol extract being particularly effective. Significant antiglycation activity was also confirmed, reducing advanced glycation end-product formation. Additionally, the extracts significantly inhibited LDL oxidation under in vitro conditions, suggesting cardiovascular protective potential. These findings support multiple complementary mechanisms for diabetes prevention and management.
medication Dosing
powder
1-3 g (single herb) or 3-6 g (as Triphala)
1-2x/day with warm water
Traditional Ayurvedic dose; taken before bed for gentle laxative action or morning for cleansing.
capsule
500 mg standardized aqueous extract
BID
Dose used in hyperuricemia clinical trial.
decoction
3-6 g dried fruit in 200 mL water, reduced by half
BID
Kwatha preparation; traditional for cough and digestive weakness.
Disclaimer: This information is largely AI-generated and reviewed by human experts at Evara Health. It is intended for educational and clinical reference purposes only and should not replace professional medical advice.
© 2026 Evara Health. All rights reserved.